{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:16:20Z","timestamp":1740104180414,"version":"3.37.3"},"reference-count":5,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T00:00:00Z","timestamp":1509667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1002\/ajh.24934","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T08:32:45Z","timestamp":1507278765000},"source":"Crossref","is-referenced-by-count":0,"title":["Transformation of MDS\/MPN\u2010RS\u2010T to AML: Trisomy 13, resistant thrombocytosis and transient disease control with oral busulfan therapy"],"prefix":"10.1002","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6562-0767","authenticated-orcid":false,"given":"Aisling","family":"Barrett","sequence":"first","affiliation":[{"name":"Department of Hematology Beaumont Hospital Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Catherwood","sequence":"additional","affiliation":[{"name":"Department of Hemato\u2010Oncology Belfast City Hospital Belfast United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Thornton","sequence":"additional","affiliation":[{"name":"Department of Hematology Beaumont Hospital Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Hematology Beaumont Hospital Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Quinn","sequence":"additional","affiliation":[{"name":"Department of Hematology Beaumont Hospital Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24637"},{"key":"e_1_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.053918"},{"key":"e_1_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24332"},{"key":"e_1_2_2_6_1","first-page":"34e69","article-title":"Refractory anaemia with ring sideroblasts associated with marked thrombocytosis (RARS\u2010T) and JAK2V617F mutation transformed to acute myeloid leukaemia with chromosomal evolution including monosomy 7","author":"Pich A","year":"2010","journal-title":"Leuk Res."}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.24934","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.24934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:15:12Z","timestamp":1695539712000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.24934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,3]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1002\/ajh.24934"],"URL":"https:\/\/doi.org\/10.1002\/ajh.24934","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"type":"print","value":"0361-8609"},{"type":"electronic","value":"1096-8652"}],"subject":[],"published":{"date-parts":[[2017,11,3]]}}}